Unimack International Group
Mohamed Yakout is a seasoned professional with extensive experience in business development and strategic management within the pharmaceutical and healthcare sectors. Currently serving as Strategic Business Director at Unimack International Group since May 2023, Mohamed oversees a team focused on sales, marketing, business development, regulatory affairs, and design. Prior roles include Director of Business Development, Head of Business Development & Portfolio Management, and Business Development Manager at MACRO GROUP Pharmaceuticals from August 2020 to August 2023. Additionally, Mohamed held senior marketing and commercial positions at Helcomin Netherlands, Sandoz, and Sanofi, where responsibilities included managing marketing functions and sales teams across the Gulf Cooperation Council (GCC) region. Mohamed began a career in sales as a Medical Representative with Eli Lilly and Company. Educational qualifications include an MBA in Marketing from the University of Leicester and a Bachelor's degree in Pharmaceutical Science from Suez Canal University.
This person is not in any teams
Unimack International Group
About Us: Unimack is a leading pharmaceutical company that specializes in the production of high-quality nutraceuticals in all dosage forms, including sachets, liquids, capsules, and tablets. We are committed to improving the health and well-being of our customers by producing safe and effective products that treat a wide range of therapeutic areas, including male and female general health, joint health, nervous system health, heart health, and many more. Our state-of-the-art facilities are equipped with cutting-edge technology and staffed by a team of highly skilled professionals who are dedicated to ensuring the quality and safety of our products. Our plants possess a microbiology lab, chemical lab, Quality control lab, and an R&D lab, which enables us to conduct rigorous testing and research to develop new and innovative products.